540737 — Shree Ganesh Remedies Share Price
0.000.00%
Last trade - 00:00- IN₹7.33bn
- IN₹7.59bn
- IN₹902.20m
- 57
- 10
- 85
- 49
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.35 | ||
| Price to Tang. Book | 7.37 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.24 | ||
| EV to EBITDA | 23.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 20.5% | ||
| Return on Equity | 26.04% | ||
| Operating Margin | 23.15% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 353.14 | 584.26 | 490.82 | 712.88 | 902.2 | n/a | n/a | 27.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +13.15 | +28.62 | +1.35 | +37.37 | +30.28 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shree Ganesh Remedies Limited is an India-based company, which is engaged in the business of bulk drug intermediates. The Company is a supplier of pharmaceutical intermediates and specialty chemicals with chlorination, Grignard reaction, hydrogenation, and high-vacuum distillation. The Company's products include intermediates by active pharmaceutical ingredient (API), and fine and specialty chemicals. It offers services, including customized chemistry and manufacturing, assets and infrastructure and key technologies and expertise. It offers its solutions to the markets, such as life sciences: human health and veterinary, flavor and fragrance, polymer industries, electronics, and agro chemicals. The Company has a portfolio of approximately 39 drug intermediates, and 18 specialty chemical products. It also delivers a service of contract manufacturing for chemical reactions like amination, amidation, alkylation, bromination, catalytic hydrogenation and chlorination.
Directors
- Chandulal Kothia CHM
- Suresh Panchal CFO
- Aditya Patel CCO
- Gunjan Kothia EDR (29)
- Parth Kothia EDR (25)
- Jayesh Savjani IND
- Priyam Shah IND
- Vaishaliben Vadodariya IND (26)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 27th, 1995
- Public Since
- October 13th, 2017
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 12,006,727
- Address
- Plot no-6011,G.I.D.C Estate, ANKLESHWAR, 393002
- Web
- https://www.ganeshremedies.com/
- Phone
- +91 2646227777
- Auditors
- Rushik J Patel & Co
Upcoming Events for 540737
Q1 2025 Shree Ganesh Remedies Ltd Earnings Release
Shree Ganesh Remedies Ltd Annual Shareholders Meeting
Similar to 540737
Chemo Pharma Laboratories
Bombay Stock Exchange
Indo US Bio-Tech
Bombay Stock Exchange
Jeevan Scientific Technology
Bombay Stock Exchange
Transgene Biotek
Bombay Stock Exchange
Vanta Bioscience
Bombay Stock Exchange
FAQ
What is the Shree Ganesh Remedies share price?
As of Today at 19:19 UTC, shares in Shree Ganesh Remedies are trading at IN₹610.30. This share price information is delayed by 15 minutes.
How has the Shree Ganesh Remedies share price performed this year?
Shares in Shree Ganesh Remedies last closed at IN₹610.30 and the price had moved by +93.72% over the past 365 days. In terms of relative price strength the Shree Ganesh Remedies share price has outperformed the S&P BSE 100 Index by +50.25% over the past year.
What are the analyst and broker recommendations for Shree Ganesh Remedies?
There is no consensus recommendation for this security.
What is the Shree Ganesh Remedies dividend yield?
The Shree Ganesh Remedies dividend yield is 0.08% based on the trailing twelve month period.
Does Shree Ganesh Remedies pay a dividend?
Last year, Shree Ganesh Remedies paid a total dividend of IN₹0.50, and it currently has a trailing dividend yield of 0.08%. We do not have any data on when Shree Ganesh Remedies is to next pay dividends.
When does Shree Ganesh Remedies next pay dividends?
We do not have data on when Shree Ganesh Remedies is to next pay dividends. The historic dividend yield on Shree Ganesh Remedies shares is currently 0.08%.
How do I buy Shree Ganesh Remedies shares?
To buy shares in Shree Ganesh Remedies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shree Ganesh Remedies?
As of the previous close price of IN₹610.30, shares in Shree Ganesh Remedies had a market capitalisation of IN₹7.33bn.
Where are Shree Ganesh Remedies shares listed?
Here are the trading details for Shree Ganesh Remedies:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 540737
What kind of share is Shree Ganesh Remedies?
Based on an overall assessment of its quality, value and momentum Shree Ganesh Remedies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shree Ganesh Remedies share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Shree Ganesh Remedies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shree Ganesh Remedies. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +8.63%.
As of the last closing price of IN₹610.30, shares in Shree Ganesh Remedies were trading +7.48% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shree Ganesh Remedies PE Ratio?
The Shree Ganesh Remedies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹610.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shree Ganesh Remedies?
Shree Ganesh Remedies' management team is headed by:
- Chandulal Kothia - CHM
- Suresh Panchal - CFO
- Aditya Patel - CCO
- Gunjan Kothia - EDR
- Parth Kothia - EDR
- Jayesh Savjani - IND
- Priyam Shah - IND
- Vaishaliben Vadodariya - IND